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Abstract
Background: Most cases of echinococcal disease (ED) acquired in Canada are thought to be due
to the sylvatic form of Echinococcus granulosus, which may be more benign than ED due to either
Echinococcus multilocularis or the pastoral form of E. granulosus. There are limited descriptions of the
clinical course and outcome of Canadian patients with ED in the modern era.
Methods: A retrospective chart review was performed of patients hospitalized with echinococcal
disease (ED) from 1991 to 2001 in Edmonton, Alberta.
Results: Forty-two cases of ED were identified of which 19 were definite, 3 probable, and 20
possible. Further analysis was limited to the 22 definite and probable cases, of which 77% were
female and 41% aboriginal, with an age range of 5 to 87 years. Nine patients (40%) had pulmonary
involvement and 11 (50%) hepatic involvement. One patient had an intracardiac mass presenting as
a cerebrovascular event and one had a splenic cyst. Seven of the 22 patients had combined surgical
resection and medical treatment, six had surgical resection of the cyst alone, four had cyst
aspiration, one had medical treatment alone and four had no specific treatment. There was no
mortality attributable to ED but three patients died of unrelated illnesses.
Conclusion:  Echinococcal disease in northern Alberta has a marked diversity of clinical
presentations, and generally has a good prognosis despite a wide variety of therapeutic
interventions.
Background
Echinococcal disease (ED) is a zoonotic infection caused
by cestodes of the genus Echinococcus. Alveolar echinococ-
cosis results from infection with the species Echinococcus
multilocularis. Disease occurs in the Northern Hemisphere
including Alaska, Japan, China, Russia and most countries
in continental Europe [1], and results in multilocular
cystic lesions. Cystic echinococcosis (CE) results from
infection with the species Echinococcus granulosus. Disease
occurs worldwide with the highest incidence in Mediterra-
nean countries, Russia and the adjacent newly independ-
ent states, China, north and east Africa, Australia, and
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South America [1]. Echinococcus granulosus infections have
been further classified as pastoral or sylvatic variants or
biotypes. In the pastoral variant, sheep serve as the most
common intermediate hosts while in the sylvatic variant
the usual intermediate hosts are caribou or moose.
Most cases of ED acquired in Canada are thought to be
due to the sylvatic form of E. granulosus. In the Northwest
Territories and the northern portion of the Canadian Prai-
rie Provinces of Alberta, Saskatchewan and Manitoba, the
barren ground caribou is the most common intermediate
host [2]. Moose with hydatid cysts have been found in
every province of Canada west of the Maritimes and it is
estimated that 50% of moose in Ontario and British
Columbia are infected with the parasite [3]. Hydatid cysts
have also been found in wapiti, elk, reindeer, coastal deer,
white tail deer and bison. The definitive host is a canine
(dog, fox, or wolf) that harbors the tapeworm after inges-
tion of tissue from an infected intermediate host. Twenty-
eight to fifty percent of dogs in the Northwest Territories
are infected with E. granulosus [2]. Intermediate hosts or
humans can ingest eggs shed in the feces of the definitive
host, with humans being dead-end hosts. Ingestion of E.
granulosus eggs by intermediate hosts or humans is fol-
lowed by the release of an oncosphere; the larva is subse-
quently transported via the blood stream or lymphatics to
primary target organs (the lung or liver, and rarely the cen-
tral nervous system, bone, or myocardium). Within the
affected organ, the oncosphere matures into a vesicle,
which grows expansively by concentric enlargement. A
fully mature hydatid cyst, normally fluid-filled and
unilocular, represents the final stage [4].
Edmonton is a referral center for northern Alberta and the
Northwest Territories, thereby affording us an opportu-
nity to see the complications of hydatid disease. We
reviewed a decade of our experience with ED to gain fur-
ther understanding of the epidemiological and clinical
features of this disease.
Methods
A retrospective chart review was performed of all cases
identified as ED using International Classification of Dis-
ease (ICD) Ninth Edition codes [ICD-9 122.0 to 122.9]
from 1991 – 2001 in all Edmonton regional hospitals.
Demographic, clinical and diagnostic data were collected.
Aboriginal persons were defined as self-identified native
Indian or Inuit people, or individuals with addresses that
were on reserve land.
Definite ED was defined by evidence of ED on pathology
(hooklets, brood capsules, or parasitic degenerative ele-
ments), probable ED by positive serology for Echinococcus
and possible ED by a clinical presentation compatible
with ED but with no corroborative histologic or serologic
evidence.
Ultrasounds of all cystic lesions from patients who met
the study criteria were reviewed by a radiologist who was
blinded as to whether the patients had possible, probable,
or definite ED. Cysts were then classified according to the
proposed international classification system [5].
Results
Illustrative case
A 28-year-old aboriginal female who was five days post-
partum had productive cough, pleuritic chest pain, dysp-
nea, fever, chills and sweating, and had received
cephalexin, ciprofloxacin and cloxacillin without clinical
improvement. She lived in an aboriginal community and
had a history of contact with dogs and the ingestion of
meat from a variety of wild animals. Laboratory results
included a white blood cell count of 13.3 × 109/L, with 1.8
× 109/L (14%) eosinophils, erythrocyte sedimentation
rate of 47 mm/hr, AST 32 U/L, and ALT 112 U/L. The chest
radiograph showed a cavity in the left lower lobe and lin-
gula with an air fluid level. Computed tomography of the
chest showed a solitary (4.5 × 6.3 × 7.7 cm) lingual cavity
with calcification, septation and a small amount of fluid
with an opacity in the posterior segment of apico-poste-
rior segment of the left upper lobe in addition to a left
pleural effusion.
The patient underwent thoracotomy and left segmental
pneumonectomy, left lingulectomy and decortication of
the lung. Histologic examination of the lung cysts showed
occasional hooklets and degenerative parasitic elements.
She had a relatively uncomplicated post operative recov-
ery and was discharged on albendazole 400 mg PO bid for
4 weeks. Echinococcal serology revealed an antibody titer
to Echinococcus of 1:1024 using an Enzyme-linked immu-
nosorbent assay (ELISA) technique.
Review of cases
Demographics
Forty-two cases of ED were identified, of which 19 were
classified as definite, 3 as probable, and 20 as possible.
The demographic features are shown in Table 1. Of the 22
definite and probable cases, 77% were female and 41%
were aboriginal. The mean age of the definite and proba-
ble cases was 32 years (range 5 – 87 years). Possible cases
were predominantly male (55%) and older (mean age 54
years). Eight of the total 42 patients had a history of eating
caribou, elk or moose meat. Seven patients had a history
of contact with dogs, and none had a history of contact
with foxes or wolves. Unfortunately this information was
not consistently recorded in the patient records.BMC Infectious Diseases 2005, 5:34 http://www.biomedcentral.com/1471-2334/5/34
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Of the 22 definite and probable cases of ED, 9 (40%) had
pulmonary involvement, 11 (50%) had hepatic involve-
ment, one (5%) had splenic involvement and one (5%)
had cerebral disease. The patient with cerebral disease was
a 28-year-old woman with cerebral emboli, who had a
pre-operative diagnosis of cardiac myxoma based on
echocardiography and magnetic resonance imaging. The
cardiac mass was resected and found to be an echinococ-
cal lesion. Ten percent of the possible ED patients had
pulmonary lesions, 80% had hepatic lesions, and 10%
had non-hepatic intra-abdominal lesions (an immigrant
from Poland with a calcified 10 cm diameter cyst in the
spleen, and a man with adenocarcinoma of the rectum
who had several calcified cysts in the right kidney).
The presenting symptoms of the 38 patients with pulmo-
nary or hepatic disease are shown in Table 2. Predominant
symptoms were pleuritic chest pain (82%), cough (73%),
and dyspnea (56%) in the patients with pulmonary
involvement, and abdominal pain (64%) in the patients
with hepatic involvement.
Investigations
Results of laboratory investigations in the 38 patients with
pulmonary or hepatic disease are shown in Table 3. Mild
anemia was common, and 37% of the 19 patients with
definite and probable ED who had a differential white
blood cell count performed had eosinophilia. Of the12
patients with definite and probable pulmonary or hepatic
ED who had ELISA testing performed, six had positive
Table 1: Demographic features of 42 patients hospitalized in Edmonton, Alberta with echinococcal disease 1991–2001
Definite/Probable (N = 22) Possible (N = 20) Total (N = 42)
Male 5 (23%) 11 (55%) 16 (38%)
Female 17 (77%) 9 (45%) 26 (62%)
Born in Canada 14 (64%) 14 (70%) 28 (67%)
Foreign born* 4 (18%) 2 (10%) 6 (14%)
Place of birth unknown 4 (18%) 4 (20%) 8 (19%)
Edmonton residence 6 (27%) 6 (30%) 12 (29%)
NWT residence 9 (41%) 8 (40%) 17 (40%)
Rural Alberta residence 7 (32%) 6 (30%) 13 (31%)
Mean age (years) 32 ± 16 54 ± 25
Pulmonary disease 9 (40%) 2 (10%) 11(26%)
Hepatic disease 12 (55 %) 16 (80%) 28 (67%)
Spleen /kidney 0 2 (10%) 2 (5%)
Cardiac 1 (5%) 0 1 (2%)
*Patients were born in Lebanon, Ukraine, Iraq, Paraguay, Poland, or Yugoslavia
Table 2: Symptoms in 38 patients with echinococcal disease and pulmonary or hepatic involvement
Pulmonary Hepatic
Symptom Definite/probable (N = 9) Possible (N = 2) Definite/probable (N = 11) Possible (N = 16)
Asymptomatic 0 0 2 2
Weight loss 2 2 1 2
Pleuritic chest pain 7 2 1 2
C o u g h 6214
Hemoptysis 1 1 0 1
D y s p n e a 5124
Abdominal pain 0 0 9 9
F e v e r 3045
Night sweats 2 0 1 2
A n o r e x i a 4014
Malaise 2 1 1 2
J a u n d i c e 2012
Chills 1 0 3 1
Vomiting 4 0 2 4BMC Infectious Diseases 2005, 5:34 http://www.biomedcentral.com/1471-2334/5/34
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results. Testing was performed using a titer method (four
of seven were positive) or an optical density method (two
of five were positive).
Results of chest radiographs for the 38 patients with pul-
monary or hepatic involvement are shown in Table 4. Six
of the 11 lesions in the patients with pulmonary involve-
ment were in the left lung with either a cystic mass
(present in nine of 11 cases) or nodular appearance asso-
ciated with a pleural effusion in five of nine pulmonary
cases. One patient had a pneumonic presentation with no
cyst. Four of the 27 patients with hepatic disease had mul-
tiple liver cysts. The right lobe of the liver was involved in
about two-thirds of the hepatic cases.
Ultrasounds were available for review in 15 of the 30
patients with intra-abdominal disease. Results are shown
in Table 5 with seven showing active cysts (CE1 or CE2)
and eight showing inactive cysts (CE 4 or CE5) [5].
Therapy and outcome
Treatment of all patients with is shown in Table 6. Of the
22 patients with definite and probable ED, seven had sur-
gical resections of cyst(s) combined with medical treat-
Table 3: Mean values and ranges of results of laboratory investigations in 38 patients with pulmonary or hepatic echinococcal disease *
Pulmonary Hepatic
Laboratory test
Normal values
Definite/probable
(N = 9)
Possible
(N = 2)
Definite/probable
(N = 11)
Possible
(N = 16)
Hemoglobin
135 – 175 g/L
120(112–133) 114.5(113–116) 123.7 (96–180) 124 (93–161)
White blood cell count
4–11 × 109 /L
10(6.4–18) 9.7(9.6–9.8) 8.7 (4.3–14.5) 8.26 (3.8 – 14)
Eosinophilia
>= 0.1 × 103 /L
2(0.1–7) 1.95(0.3–3.6) 1.8 (0 .1–6) 1.5 (0 .1 – 4.7)
ESR
0–20 mm/hr
28.5(10 – 47) 30.5(28–33) 32.6 (18–47) 23 (11–35)
AST
<40 U/L
30.4 (14–49) 25.5(22–29) 32 (12–59) 63 (14 – 432)
Alkaline Phosphatase
30–130 u/L
122.3(48 – 231) 137(123–152) 141 (62 – 461) 168 (41 – 892)
Total Bilirubin
3.4–17.1 umol/l
11(4–27) 4.5(2–7) 15.7 (4–32) 24.4 (3.3 – 98)
ELISA
(positives/ number tested)
3/7 0/2 3/5 0/5
Legend: ELISA – enzyme-linked immunosorbent assay; ESR – erythrocyte sedimentation rate
* Results are incomplete in some patients.
Table 4: Chest radiographic findings in 42 patients with echinococcal disease
Pulmonary Hepatic Other
Chest 
radiograph
Definite/probable 
N = 9
Possible N = 2 Definite/ probable 
N = 11
Possible N = 16 Cardiac (definite) 
N = 1
Kidney or spleen 
(probable/
possible) N = 3
N o r m a l 005701
A b n o r m a l 926912
C y s t 720200
P l e u r a l  e f f u s i o n 414310
P n e u m o n i a 510400
C a v i t y 211000
G r a n u l o m a 001000
A t e l e c t a s i s 101301
Calcified cyst 620100BMC Infectious Diseases 2005, 5:34 http://www.biomedcentral.com/1471-2334/5/34
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ment (albendazole or mebendazole), six had surgical
removal of the cyst alone, four had cyst aspiration, one
had medical treatment alone and four were not specifi-
cally treated. Of the 20 cases with probable ED, one had
surgical resections of cyst combined with medical treat-
ment, one had surgical removal of the cyst alone, one had
medical treatment alone and 17 were not specifically
treated. Pre-operative complications included suspected
rupture of a cyst into a bronchus in two patients, sus-
pected bacterial infection of the cyst in two patients with
pulmonary cysts and one patient with a hepatic cyst, and
obstructive jaundice in one patient. Major complications
after surgical resection occurred only with hepatic disease
and included single cases of pleural effusion, wound
infection, biliary leak, and intra-abdominal bleeding
resulting in a hepatic lobectomy.
Three patients with possible hepatic ED died of illnesses
that were not directly related to ED. The first patient had
cryptogenic cirrhosis and chronic cholelithiasis, as well as
a left lobe liver cyst. She had an open cholecystectomy for
acute cholecystitis, and died post-operatively from intra-
abdominal bleeding and sepsis (pathology was not per-
formed on the hepatic cyst). The second patient with
multiple myeloma and paraplegia was incidentally noted
to have a hepatic cyst and died of unexplained respiratory
failure. The third patient admitted with bilateral deep vein
thromboses and incidentally found to have hepatic cysts
died of bronchopneumonia and heart failure.
Comparison of Canadian-born to foreign-born patients
In comparing the clinical features and outcome of Cana-
dian-born patients (presumed to have the sylvatic variant
of E. granulosus) and foreign-born patients (who could
have any type of Echinococcus infection), no differences
were noted (data not shown).
Discussion
Over a ten-year period there were 19 definite, 3 probable,
and 20 possible cases of ED identified at a northern
Alberta referral center. In North America, ED was previ-
ously considered a disease of immigrants. Of 596 cases of
ED reported up to 1950, only 36 occurred in persons born
in Canada or the United States [3]. In our series, only 6 of
Table 5: Ultrasound findings in 15 patients with intra-abdominal cystic echinococcosis graded according to the proposed international 
classification (5)*
Definite/probable hepatic (N = 4) Possible hepatic (n = 8) Possible kidney (N = 1) Probable splenic (N = 1) Possible splenic (N = 1)
CL - - - - -
CE1 - 3 1 - -
CE2 1 2 - - -
CE3 - - - - -
CE4 3 - - 1 1
CE5 - 3 - - -
*Ultrasounds were no longer available for review on the other 15 patients with intra-abdominal disease.
Table 6: Therapy of patients with hydatid disease
Pulmonary Hepatic Other
Therapy Definite/probable 
N = 9
Possible N = 2 Definite/probable 
N = 11
Possible N= 16 Cardiac (definite) 
N = 1
Kidney or spleen 
(probable/
possible) N = 3
Medical only* 0 1 1 0 0 0
Surgical resection only 3 0 2 1 1** 0
Medical therapy and 
surgical resection
50 21 00
Aspiration of cyst only 0 0 4 0 0 0
Aspiration of cyst and 
medical treatment
00 00 00
Observation only 1 1 2 14 0 3
* mebendazole or albendazole
**echinococcal cyst was resected from left ventricleBMC Infectious Diseases 2005, 5:34 http://www.biomedcentral.com/1471-2334/5/34
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36 cases where the country of birth was known were for-
eign-born. Forty-one percent of the 42 cases occurred in
aboriginal Canadians, who represent only 5.3% of the
population of Alberta and 3.4% of the population of Can-
ada (2001 Canadian census data). The majority of
patients were middle-aged females. Previous studies have
shown a predominance of males [4] and females [6], and
it has been postulated that the sex predominance may be
determined by which sex has more contact with the usual
definitive host in that country [3].
Two-thirds of the cases of ED in our study were pulmo-
nary, but for the definite and probable cases, half were
hepatic. A previous study from northern Canada and the
United States described hepatic involvement in 71% of
cases and pulmonary involvement in only 7% of cases [4].
The results of a recent study of 17 patients from Manitoba
and northwestern Ontario were comparable to ours with
pulmonary involvement in 47% and hepatic involvement
in 47% of cases [7]. However, the true rate of hepatic ver-
sus pulmonary ED cannot be determined by these studies
as detection is often on the basis of radiographic studies
performed for reasons unrelated to the ED. Previous
reviews suggested that pulmonary cysts are more common
in children and young adults while hepatic cysts are more
common in older persons [2], which is compatible with
our findings (data not shown).
Laboratory tests are of limited value in the diagnosis of
ED. One study showed that only 29% of cases with pul-
monary cysts and 15% of cases with hepatic cysts had
eosinophilia [8]. In our series, 54 % of the pulmonary
cases and 22% of the hepatic cases had eosinophilia. Per-
haps this low rate is explained by the chronicity of the dis-
ease with eosinophilia being present only early in the
course via stimulation of Th2 lymphocytes and produc-
tion of IL-4 and IL-5 subsequently generating IgG1 and
IgE-secreting cells, and eliciting eosinophilia [9,10].
Another possibility is that eosinophilia is only likely after
cyst rupture and release of antigenic material [11].
Serology for ED has variable sensitivity depending on the
type of test. The most sensitive is IgG ELISA with an 83%
sensitivity [10] although this test may only become posi-
tive after cyst rupture [11]. In our study, serology was pos-
itive in 54% of cases of definite and probable ED.
There are no clinical features that can reliably distinguish
E. granulosus from E. multilocularis. However, a specific E.
multilocularis  antigen such as the high affinity purified
Em2 antigen AE metacestodes has been reported to be
able to discriminate between E. granulosus and E. multiloc-
ularis in 95% of cases [12]. This test was not available at
the time of this review. Molecular methods to distinguish
the pastoral from the sylvatic form of E. granulosus have
recently been described [13]. Daughter cysts have not
been reported in sylvatic disease [14], and this form of the
disease appears to be more benign than the pastoral form
with a far lower incidence of complications even when
cyst rupture occurs [14]. Most cases of the sylvatic form of
ED are asymptomatic and are diagnosed when cysts are
found during procedures performed for other reasons
[14]. It seems likely that most of our Canadian-born
patients had sylvatic disease as they reside in areas where
exposure to sheep is rare. Most of our patients with pul-
monary cysts were minimally symptomatic on presenta-
tion with cough or chest pain, and cyst rupture was
recognized in only two pulmonary cases. In addition, four
patients with definite and probable ED were discharged
with no therapy and had no apparent sequelae.
Traditionally, surgical resection of the cyst was the treat-
ment for ED, but simpler surgical procedures such as
hydatid cyst aspiration have been shown to result in low
mortality and improved outcome [6]. However, medical
management of relatively asymptomatic presumed syl-
vatic cases can be considered, as the natural history of the
sylvatic variant is to rupture without any complications or
anaphylaxis [14]. It is not clear if albendazole or meben-
dazole are indicated or if observation is sufficient. Surgical
resection or cyst aspiration is recommended in sylvatic
cases only for complications such as secondary infection
or pressure symptoms.
Although the outcome of our patients was generally good
complications did occur. Two patients had symptomatic
rupture of a pulmonary cyst and two patients had sus-
pected bacterial infection of pulmonary cysts. Pressure or
mass effects of hepatic cysts on the bile ducts, portal and
hepatic veins, or on the inferior vena cava can result in
cholestasis, portal hypertension, venous obstruction, or
Budd-Chiari syndrome, sometimes resulting in the need
for liver transplantation [15]. Obstructive jaundice was
described in 18% of 132 patients in one case series [16]
and occurred in one of our 12 definite and probable
hepatic cases. Rupture of cysts into the biliary tree can
produce biliary colic, obstructive jaundice, cholangitis or
pancreatitis [17]. Cerebral disease is more common in
children than in adults, and occurs in 1.5%–2.0% of
patients, with the most common presentations being sei-
zures or signs of raised intracranial pressure secondary to
the cysts in the brain [7]. In our single case, cerebral dis-
ease was due to emboli from a cardiac echinococcal
lesion.
Conclusion
Prevention of ED has been attempted by distributing
praziquantil bait in areas where there is a high prevalence
of infected foxes [18]. Unfortunately, such strategies are
not practical in a vast country such as Canada. Until ourPublish with BioMed Central    and   every 
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understanding of the modes of transmission of ED
improves, education of the public about this relatively
rare disease is unlikely to be effective. Therefore, from a
public health perspective, the emphasis must be on fur-
ther progress in management of this disease, which will
require increasing awareness on the part of physicians
regarding the multitude of presentations, improved diag-
nostics, and further study of long-term outcomes with dif-
ferent treatment modalities.
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